Compare ANL & FOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ANL | FOR |
|---|---|---|
| Founded | 2004 | 2005 |
| Country | Singapore | United States |
| Employees | N/A | 402 |
| Industry | | Real Estate |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 998.8M | 1.1B |
| IPO Year | 2022 | 2007 |
| Metric | ANL | FOR |
|---|---|---|
| Price | $10.80 | $22.25 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 3 |
| Target Price | $29.50 | ★ $34.00 |
| AVG Volume (30 Days) | ★ 268.1K | 174.4K |
| Earning Date | 08-14-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.63 |
| Revenue | N/A | ★ $1,662,400,000.00 |
| Revenue This Year | $243.83 | N/A |
| Revenue Next Year | N/A | $8.43 |
| P/E Ratio | ★ N/A | $13.58 |
| Revenue Growth | N/A | ★ 10.14 |
| 52 Week Low | $0.88 | $22.04 |
| 52 Week High | $17.25 | $32.06 |
| Indicator | ANL | FOR |
|---|---|---|
| Relative Strength Index (RSI) | 46.74 | 33.33 |
| Support Level | $8.95 | N/A |
| Resistance Level | $11.90 | $26.36 |
| Average True Range (ATR) | 0.99 | 0.91 |
| MACD | 0.25 | -0.24 |
| Stochastic Oscillator | 72.55 | 4.79 |
Adlai Nortye Ltd is a clinical-stage company at the forefront of discovering and developing cancer therapies. The company is building a robust pipeline of drug candidates focused on two key areas where it believes it can make a difference RAS-targeting therapies: its is tackling RAS-driven cancers with AN9025, an oral pan-RAS(ON) inhibitor, and AN4035, a CEACAM5-targeting ADC delivering a potent pan-RAS(ON) inhibitor directly to tumors; Next-generation cancer immunotherapies: its candidates, AN8025 (a tri-functional fusion protein of alphaPD-L1 x CD86 variant x LAG3 variant), a T-cell and antigen-presenting cell modulator, and AN4005 (a first-in-class oral small-molecule PD-L1 inhibitor), are designed to activate cancer immunity in novel ways.
Forestar Group Inc is a residential lot development company engaged in land acquisition and development for the sale of finished single-family residential lots to local, regional, and national homebuilders. The company operates through a single real estate segment, which acquires land, installs infrastructure for residential communities, and generates all revenue from lot sales. Its communities mainly support entry-level, first-time move-up, and active-adult homes, with certain communities also marketed to build-to-rent operators. The company generally invests in entitled, short-duration projects that can be developed in phases to align lot production with market demand and support efficient capital deployment.